Pfizer Q3 Earnings: Revenue And Profit Beat On Heightened Demand For Paxlovid,...

Published on 29 Oct 2024 on Benzinga · via Yahoo Finance

On Tuesday, Pfizer Inc. (NYSE:PFE) reported third-quarter adjusted EPS of $1.06, a turnaround from...

Read the rest of the article

Start tracking your investments with Statfolio

Insider Activity: Thursday's Top Buys and Sells in US Stocks

Investing.com 1 Nov 2024

Pfizer PFE reported stronger third-quarter results than we anticipated, largely due to significan...

Morningstar 29 Oct 2024

On Tuesday, Pfizer Inc. (NYSE:PFE) reported third-quarter adjusted EPS of $1.06, a turnaround fro...

Benzinga · via Yahoo Finance 29 Oct 2024

With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab i...

Benzinga 29 Oct 2024

Investors and analysts said they want to see improved profitability following the company's billi...

Reuters 28 Oct 2024

The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient...

The Wall Street Journal 26 Oct 2024

On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine...

Benzinga · via Yahoo Finance 23 Oct 2024

Smith is also Starboard's chief investment officer. Starboard has built a $1 billion position in...

Reuters 22 Oct 2024

(NYSE:PFE), holding the pharmaceutical giant’s management accountable for failing to deliver on i...

Benzinga · via AOL 22 Oct 2024

We recently compiled a list of the 10 Worst Performing Blue Chip Stocks in 2024. In this article,...

Insider Monkey · via Yahoo Finance 21 Oct 2024